<?xml version="1.0" encoding="UTF-8"?>
<!-- generator="wordpress.com" -->
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd"
	xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
	xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
	xmlns:image="http://www.google.com/schemas/sitemap-image/1.1"
	>
<url><loc>https://blog.lifesciencenation.com/2026/09/01/hot-investor-mandate-cross-border-early-stage-vc-invests-150k-1m-in-techbio-and-technology-enabled-healthcare-companies/</loc><news:news><news:publication><news:name>Next Phase Newsletter</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-09-01T16:00:09+00:00</news:publication_date><news:title>Hot Investor Mandate: Cross-Border Early-Stage VC Invests $150K–$1M in TechBio and Technology-Enabled Healthcare Companies</news:title><news:keywords>technology, health, AI, business, entrepreneurship, finance, investing, artificial-intelligence</news:keywords></news:news></url><url><loc>https://blog.lifesciencenation.com/2026/09/01/hot-investor-mandate-us-based-healthcare-focused-fund-invests-around-10m-in-companies-developing-novel-therapeutics-open-to-various-modalities/</loc><news:news><news:publication><news:name>Next Phase Newsletter</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-09-01T15:59:43+00:00</news:publication_date><news:title>Hot Investor Mandate: US-Based Healthcare Focused Fund Invests Around $10M in Companies Developing Novel Therapeutics, Open to Various Modalities</news:title><news:keywords>technology, health, AI, business, entrepreneurship, finance, investing, artificial-intelligence</news:keywords></news:news></url><url><loc>https://blog.lifesciencenation.com/2026/09/01/hot-investor-mandate-global-cvc-invests-1-3m-in-healthcare-and-life-sciences-companies-through-evergreen-fund/</loc><news:news><news:publication><news:name>Next Phase Newsletter</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-09-01T15:59:23+00:00</news:publication_date><news:title>Hot Investor Mandate: Global CVC Invests $1–3M in Healthcare and Life Sciences Companies Through Evergreen Fund</news:title><news:keywords>technology, health, AI, business, entrepreneurship, finance, investing, artificial-intelligence</news:keywords></news:news></url><url><loc>https://blog.lifesciencenation.com/2026/09/01/hot-investor-mandate-vc-with-global-investment-mandate-seeks-seed-to-series-b-therapeutics-medtech-and-digital-health-companies/</loc><news:news><news:publication><news:name>Next Phase Newsletter</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-09-01T15:59:07+00:00</news:publication_date><news:title>Hot Investor Mandate: VC With Global Investment Mandate Seeks Seed to Series B Therapeutics, Medtech, and Digital Health Companies</news:title><news:keywords>technology, health, AI, business, entrepreneurship, finance, investing, artificial-intelligence</news:keywords></news:news></url><url><loc>https://blog.lifesciencenation.com/2026/09/01/resi-boston-2026-innovators-pitch-challenge-finalists/</loc><news:news><news:publication><news:name>Next Phase Newsletter</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-09-01T13:25:24+00:00</news:publication_date><news:title>RESI Boston 2026 Innovator’s Pitch Challenge Finalists </news:title><news:keywords>venture capital, news, science, entrepreneur, technology, startups, networking, marketing, health, travel, AI, business, entrepreneurship, food, finance, art, writing, books, digital-marketing, education, social-media, sustainability, dailyprompt</news:keywords></news:news></url><url><loc>https://blog.lifesciencenation.com/2026/09/01/bayer-co-lab-joins-resi-boston-2026-as-title-sponsor/</loc><news:news><news:publication><news:name>Next Phase Newsletter</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-09-01T13:25:21+00:00</news:publication_date><news:title>Bayer Co.Lab Joins RESI Boston 2026 as Title Sponsor </news:title><news:keywords>venture capital, Healthcare, news, entrepreneur, technology, startups, marketing, health, travel, AI, business, entrepreneurship, food, finance, investing, writing, books, beauty, education, social-media, lifestyle, facebook, twitter, adventure</news:keywords></news:news></url><url><loc>https://blog.lifesciencenation.com/2026/09/01/where-cross-border-deal-flow-actually-happens/</loc><news:news><news:publication><news:name>Next Phase Newsletter</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-09-01T13:25:19+00:00</news:publication_date><news:title>Where Cross-Border Deal Flow Actually Happens </news:title><news:keywords>venture capital, Healthcare, news, science, technology, mental health, startups, marketing, health, travel, AI, business, entrepreneurship, finance, investing, artificial-intelligence, art, writing, books, politics, digital-marketing, fitness, beauty, history, education, lifestyle, leadership, inspiration, chatgpt, sustainability, dailyprompt</news:keywords></news:news></url></urlset>